Relationship of Hemoglobin A1C and Outcomes of Treatment of Diabetic Macular Edema

Journal Title: Ophthalmology Research: An International Journal - Year 2016, Vol 6, Issue 1

Abstract

Aims: To evaluate the relationship between Hemoglobin A1c (HbA1c) and visual and anatomical outcomes in eyes following treatment with intravitreal anti vascular endothelial growth factor (VEGF) agents and corticosteroids for diabetic macular edema (DME). Study Design: Retrospective observational case series. Place and Duration of Study: Michael E. DeBakey Veterans Affairs Medical Center in Houston, Texas between January 2012 and November 2014. Methodology: Case series from a single institution of 194 eyes from 134 consecutive patients with DME in the absence of concurrent retinal disease treated with at least 3 intravitreal injections of bevacizumab, ranibizumab, or aflibercept with at least 6 months of follow-up. Results: On multivariate analysis, initial HbA1c and initial BCVA were each associated to predict final visual outcome (p = 0.003 and p =0.001, respectively). Subgroup analysis demonstrated no statistical difference in improvement in mean BCVA (p=0.11) or mean CSMT (p=0.11) among patients whose hemoglobin A1c stayed stable, increased during the study or decreased during the study, however the mean number of injections required were respectively 6.5, 9.0 and 8.1 (p=0.02). Conclusions: The visual outcome following intravitreal bevacizumab, ranibizumab, or aflibercept with or without adjunctive triamcinolone acetonide are weakly related to glycemic control at initiation of treatment. Patients with stable glycemic control during treatment require fewer injections to treat diabetic macular edema compared to patients with improvement or worsening in glycemic control.

Authors and Affiliations

Robert B. Garoon, Lai Jiang, Petros E. Carvounis, Silvia Orengo-Nania, Robert E. Coffee

Keywords

Related Articles

The Epidemiology and Type of Macular Disease Seen in a Teaching Hospital in South-West, Nigeria

Aim: To examine the epidemiology and types of macular disease in our environment in order to advocate possible preventive interventions or address current behaviours that fall within established risk factors. Study Desig...

Ishihara Electronic Color Blindness Test: An Evaluation Study

Purpose: Evaluation of computer based color deficiency test. Materials and Methods: Two hundred and sixty seven volunteers have been checked using both traditional Ishihara plates and a computer diagnosis program using L...

The Relationship of HLA-B27 and HLA-B51 on Non-Behcet Uveitis

Aims: The aim of this study was to investigate the relationship of human leukocyte antigen (HLA)-B27 and HLA-B51 on the clinical characteristics, demographic features, localization, laterality, treatment modalities and v...

Photochemical Kinetic Modeling for Oxygen-enhanced UV-light-activated Corneal Collagen Crosslinking

Aims: To derive analytic formulas for the efficacy of type-II corneal collagen crosslinking (CXL) based on coupled macroscopic kinetic equations with an emphasis on the role of oxygen. Study Design: modeling and analysi...

Traumatic Cataract

Traumatic cataract is more common in younger individuals. Traumatic cataract is an important cause of uniocular visual loss and is often sudden in onset. Traumatic lens damage may be caused by mechanical or non-mechanica...

Download PDF file
  • EP ID EP327605
  • DOI 10.9734/OR/2016/28445
  • Views 84
  • Downloads 0

How To Cite

Robert B. Garoon, Lai Jiang, Petros E. Carvounis, Silvia Orengo-Nania, Robert E. Coffee (2016). Relationship of Hemoglobin A1C and Outcomes of Treatment of Diabetic Macular Edema. Ophthalmology Research: An International Journal, 6(1), 1-7. https://europub.co.uk/articles/-A-327605